Hospital Bed Sheets Market – Growing Prevalence of Chronic Illnesses to Drive Growth

The global hospital bed sheets market is set to grow over the next few years owing to factors such as massive increase in number of patients due to increase in number and cases of viral infections. The on-going pandemic of COVID-19 for instance is driving up demand considerably.

Besides, incidence of other chronic illnesses such as CVD and COPD is also growing rapidly and this is also going to be a major growth propellant in the market as demand for disposable sheets will increase because of this. Besides, world over, number of people aged 60 and above is increasing massively.

Get Sample Copy of this Report @

Region-wise, it is quite significant to make note of the fact that while every region in the world will record growth over the next few years, it will be North America and Europe, which will carve off a notable share of the market. Demand for disposable bed sheets in the region is growing rapidly as number of patients increase rapidly. Incidence of chronic illnesses in the regions, particularly in the North American region, is high. In United States of America, six in every ten people are undergoing one such infliction.

Asia Pacific region will also be a lucrative market, owing to a large patient pool. The region will record a robust growth rate over the next few years, creating new and interesting avenues of growth. Countries that will be at the forefront of this growth are India and China. Other attractive regions will be East Asia and South Asia.

The vendor landscape of global hospital bed sheets market is fragmented. Top players include 3M Company, Medline Industries, Inc., Beaucare Medical Ltd., GPC Medical Ltd., Vaibhav Overseas, Jackson Care Product Company, EconoGroup, Essential Medical Supply Inc., Changzhou Care-de Sanitary Material Co., Ltd., Derme&Co. and others. These witness intense competition in the market and rely heavily on a robust distribution framework.

Check Table of Contents of this Report @

Artificial Intelligence in Medicine pins hope for Higher Degree of Healthcare

Artificial Intelligence (AI) is witnessing the thrust to be integrated into medicine. Reason? To allow doctors to spend more time addressing patients’ concerns. By means of using complex algorithms to identify patterns in large datasets such as current medications, lab test results, and symptoms to name a few. In fact, AI might make medicine more personal.

“At the time of patients visit to the doctor, the latter would already know what patients are experiencing,” stated a cardiologist and data researcher at Yale Medicine. This would help to detect the need for medical attention for patients before they do.

AI varies in definition from industry to industry, and from dictionary to dictionary. Broadly, in the medicine field, the use of AI involves computer systems to build algorithms based on models in raw data to find relations. This could be relation between clusters of symptoms to a particular disease that would be very hard for a person to detect.

Slew of Gadgets record Everyday Activity level to raise risk Alerts

To detect if a patient is at risk of heart failure is a hypothetical example of an AI-assisted future. Meanwhile, a heart failure is a condition where an impaired heart muscle fights to pump adequate oxygenated blood throughout the body.

For AI-driven medical assistance, a patient would begin the day by stepping on an internet-connected scale. The scale would observe changes in weight if any for possible signs of fluid retention. Besides this, the patient would strap a smart watch or other sensor to track activity level and steps, and would use a phone app to record specific signs such as shortness of breath. This data would transmit directly to the electronic health record, which would assimilate the entire information and categorize the patient’s risk, instead of waiting for the patient to consult a doctor.

Artificial Intelligence to play a role in Preventive Healthcare

For patients of diabetes and heart disease, an important part of the treatment is staying healthy outside the hospital. And, not to return to the doctor’s clinic with further complications. Nonetheless, there involves probability factor to reach out to the most vulnerable patients at the time of need than clinical assessments.

Artificial intelligence displays the potential to play a role here. The role to help clinicians handle such problems. It does so by examining large datasets to spot patients that would benefit most from preventive measures.

Nonetheless, in order to leverage artificial intelligence, this requires healthcare organizations to employ their own data scientists. Alternately, healthcare organizations can settle for one-size fits all AI solutions that are not optimized for all patients.

New Analytics Solution suitable for Raw Patient Data

To address this, the startup is playing a role. It is helping healthcare organizations leverage the power of AI with flexible analytics solution. Employing this solution, it enables healthcare organizations quickly feed their data into machine learning models and obtain actionable results.

Importantly, the platform is being used to help determine the patients that have higher probability to miss appointments, benefit from routine check-ups, acquire infections like sepsis, and more.

Furthermore, the platform finds use for health insurers as well. Health insurance companies are using ClosedLoop for population-level predictions. Such predictions are around things such as patient readmissions and the start or progression of chronic diseases.

“ClosedLoop developed a healthcare data science platform to be suitable for any kind of data that organizations have, build models specific to patients and deploy the platform,” stated the CTO of ClosedLoop.

The platform developed by ClosedLoop is of immense value. It provides the ability to use somebody’s raw data in the way it is in their system and to convert it into a model that can be readily used.

Increased Awareness about Hygiene to Trigger Growth of the Disinfection Cap Market

A surge in the occurrences of hospital acquired diseases together with the increasing cases of hospital admissions are estimated to come up as important growth factors for the global disinfection cap market in the near future. Hospital-acquired infections or nosocomial infections refer to those infections that are usually found in patients admitted in hospitals to receive long-term treatment. Mostly in cases of surgical treatment, a patient requires long-term hospitalization, which increases the risk of contracting hospital-acquired infections.

Hospital-acquired infections can be contracted at ambulatory surgical centers, clinics, surgical centers, hospitals, and at long-term care facilities like nursing homes and rehabilitation facilities. Usually, patients with low immunity, geriatric population, and children are more at risk of contracting such infections. Excessive use of antibiotics, lack of proper hygiene, and use of indwelling catheters are likely to encourage growth of the global disinfection cap market over the tenure of analysis.

Get Sample Copy of this Report @

According to a 2018 report published by European Centre for Disease Prevention and Control (ECDC), in the countries of Europe, the prevalence of hospital-acquired infections was around 7.1% and nearly 41,31,000 patients contract the infection every year in Europe alone. Such high occurrences of hospital-acquired infections demand use of disinfection caps. These caps are utilized in the disinfection of IV connectors together with removal of bacteria and various other microorganisms. This factor is likely to amplify growth opportunities for the global disinfection cap market in the forthcoming years.

Rise in the Prevalence of Cancer to Shoot Up Demand in the Market

A rise in the number of cases of chronic illnesses, such as cancer, diabetes, drives the demand for use of parenteral nutrition. This assists in the administration of vital nutrients thereby assisting in the maintenance of hydration, energy, and strength level in patients suffering from an illness. Increased prevalence of cancer is predicted to amplify the growth of the global disinfection cap market in the years to com. Disinfection caps are utilized for the purpose of decontamination of IV connectors that are used in the supply of nutrition to cancer stricken patients.

Cancer often results in the rise of abnormal functioning of gastrointestinal tract, development of various physical obstructions, and increased occurrences of stomach ulcers. All of these conditions require parenteral nutrition. In addition, cancer therapies lead to weakening of human body and strip the body of nutrients to such an extent that the patient may even die. Unintentional loss of weight and anorexia are associated with cancer and needs replenishment of nutrients parenteral route of administration, which is likely to pave way for growth of the global disinfection cap market over the period of assessment.

Driven by Rise in HAI, Asia Pacific to Offer Promising Growth Opportunities

Driven by the rising number of surgeries, North America is predicted to remain one of the prominent regions in the global disinfection cap market. In addition, a rise in the number of healthcare workers is predicted to place increased demand for disinfectants and antiseptics in North America, thereby driving the disinfection cap market in the region.

Asia Pacific is projected to come up as a rapidly growing region, all because of the rise in the number of hospital-acquired infections, typhoid fever, cholera, and food poisoning. Besides, growing awareness about cleanliness and ongoing crisis of COVID-19 is likely to generate increased demand for the product in the region.

Check Table of Contents of this Report @

Market Players to Opt for Investment in Research and Development

Some of the reputed players profiled in the study of global disinfection cap market comprise Phenomenome Discoveries Inc., Human Metabolome Technologies, Inc., Thermo Fisher Scientific, Inc., Bio- Rad Laboratories, Inc., Biocrates Life Sciences AG, and Agilent Technologies, Inc.

Increased funding in the research and development activities by the companies is likely to pave way for acquiring greater share in the market.